Quarterly report [Sections 13 or 15(d)]

Equity (Details)

v3.25.2
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
Mar. 31, 2025
Aug. 11, 2023
Aug. 31, 2020
Jun. 30, 2025
Jun. 30, 2024
Equity [Line Items]          
Gross proceeds       $ 24,652
Issuance of stock options (in Shares)       26  
Vesting period       4 years  
Stock options fair value       $ 29  
Expected life       6 years  
Expected volatility minimum       90.10%  
Expected volatility maximum       90.70%  
Expected dividends        
Stock option grant (in Shares)       1,000  
Cancellation of stock options (in Shares)       4,923  
Cancellation of stock options       $ 8,800  
Capital on Demand Sales Agreement [Member]          
Equity [Line Items]          
Aggregate amount     $ 200,000    
Restricted Stock Units (RSUs) [Member]          
Equity [Line Items]          
Stock options fair value       1,800  
Compensation expense       $ 300 300
Weighted average term       1 month 6 days  
Unrecognized compensation       $ 100  
Stock Options [Member]          
Equity [Line Items]          
Option term       10 years  
Compensation expense         $ 2,400
Unrecognized compensation expense       $ 300  
Weighted average term       2 years 2 months 12 days  
Maximum [Member]          
Equity [Line Items]          
Public float subject to market conditions       $ 75,000  
Discount rate       4.50%  
Minimum [Member]          
Equity [Line Items]          
Discount rate       4.00%  
Common Stock [Member]          
Equity [Line Items]          
Aggregate amount   $ 200,000      
Base prospectus   $ 500,000      
Sale of shares (in Shares)         2,900,000
Gross proceeds         $ 25,200
Net proceeds from issuance of common stock.         $ 24,700
Issuance of stock options (in Shares)       26,000  
Exercise price minimum (in Dollars per share)       $ 1.06  
Exercise price maximum (in Dollars per share)       $ 1.43  
Cancellation of stock options (in Shares) 4,900,000